NAICS 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
52 open opportunities · 1,433 FY2025 awards · $1.51B obligated
Top contractors in this NAICS
- Start2 Group, INC.$105.2M
- Amgen USA INC$89.9M
- L3 Technologies, INC.$71.3M
- The Boeing Company$64.5M
- Cidara Therapeutics INC$58.1M
- Siga Technologies, INC.$53.1M
Hunting recompetes here?
10+ contracts in this NAICS end within 18 months. The largest are listed below — incumbents and end dates included.
All expiring 541714 contracts →Open opportunities
Largest contracts ending within 18 months
| PIID | Contractor | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|---|
| 75A50125C00017 ↗ | Cidara Therapeutics INC | DEVELOPMENT OF CD388 AS A LONG-LASTING PROPHYLACTIC ANTI-VIRAL OPTION FOR PROTECTION AGAINST THE HEALTH IMPACTS CAUSED BY INFLUENZA | Office Of Assistant Secretary For Preparedness And Response | 541714 | $58.1M | Sep 30, 2025 | Sep 29, 2027 |
| 75A50124C00010 ↗ | Kaleo, INC. | DEVELOPMENT OF A NOVEL PRALIDOXIME CHLORIDE AUTO-INJECTOR DEVICE | Office Of Assistant Secretary For Preparedness And Response | 541714 | $26.0M | Apr 11, 2024 | Oct 31, 2027 |
| 75A50120C00169 ↗ | Locus Biosciences INC | THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO: 1.SUPPLEMENTALLY FUND CLIN 0003. 2.UPDATE KEY PERSONNEL. 3.EXTEND PERIOD OF PERFORMANCE FOR CLINS 0002 AND 0003 TO END 12/31/2026. | Office Of Assistant Secretary For Preparedness And Response | 541714 | $24.9M | Sep 28, 2020 | Dec 31, 2026 |
| 75A50120C00177 ↗ | Vedanta Biosciences, INC. | EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. | Office Of Assistant Secretary For Preparedness And Response | 541714 | $18.0M | Sep 28, 2020 | Jan 31, 2027 |
| 75A50124F61006 ↗ | Advanced Technology International | MODIFICATION UNDER RRPV OTA WITH ATI TO ADDRESS FUNDING GAPS IN INITIAL TASK ORDER. | Office Of Assistant Secretary For Preparedness And Response | 541714 | $15.0M | Mar 15, 2024 | Jun 16, 2027 |
| 36C24E25N0228 ↗ | Personalis, INC. | WHOLE GENOME SEQUENCING | Department Of Veterans Affairs | 541714 | $13.5M | Sep 30, 2025 | Sep 29, 2026 |
| 75A50122C00031 ↗ | Crossject Sa | SUPPLEMENTAL FUNDING FOR CLIN 001 AND REVISED THE STATEMENT OF WORK. | Office Of Assistant Secretary For Preparedness And Response | 541714 | $11.3M | Jun 22, 2022 | Jun 21, 2027 |
| 75N95025C00007 ↗ | Coriell Institute For Medical Research, INC. | SCIENTIFIC MANAGEMENT AND SUPPORT TO THE NATIONAL INSTITUTE OF MENTAL HEALTH (NIMH) REPOSITORY AND GENOMICS RESOURCE (NRGR) | National Institutes Of Health | 541714 | $10.7M | Aug 11, 2025 | Aug 10, 2026 |
| N0018924FZ831 ↗ | Leidos, INC. | DEPLOYMENT HEALTH RESEARCH | Department Of The Navy | 541714 | $10.5M | Aug 28, 2024 | Aug 27, 2026 |
| N0001424C1320 ↗ | Ge Energy Power Conversion Naval Systems INC. | DEVELOP AND PROTOTYPE A MW SCALE HMMC TO VALIDATE, TEST, AND MATURE THE TRL LEVEL FOR PROPULSION DRIVE APPLICATION. THE PROJECT WILL ADVANCE POWER ELECTRONICS BUILDING BLOCK TO PROVIDE FUTURE NAVAL CAPABILITIES FOR LVDC/AC AND MVDC/AC APPLICATIONS. | Department Of The Navy | 541714 | $10.4M | Aug 14, 2024 | Jun 30, 2027 |